Back

PDE1 inhibition potentiates arrhythmogenic disturbances in calcium homeostasis and electrical activity induced by pathological adenosine levels in mouse ventricular myocytes

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Molecular and genetic mechanisms of arrhythmias: from calcium dysregulation to syndromic signatures Arrhythmias ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mrs Cristina Aceituno

Biomedical Research Institute Barcelona IIBB-CSIC, Barcelona (Spain)

6 More presentations in this session

Presentation thumbnail
Synapsin 2 deficiency impairs NCX1 transport and increases susceptibility to ventricular arrhythmias and heart failure mortality
Doctor A. Ottesen (Nordbyhagen, NO)
Abstract Slides Video
Presentation thumbnail
Identification of a small SN derivative that inhibits CaMKII activity
Miss I. Rugolo (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Digging into the pathophysiological complexity of CPVT5
Mr K. Hernandez Lopez (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Peptide array-derived optimized secretoneurin variants enhance CaMKII inhibition and reduce pathological cardiomyocyte Ca2+ handling
Miss I. Rugolo (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Genetic analysis and electrocardiographic patterns in Brugada syndrome
Miss M. Modena (Pisa, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Molecular and genetic mechanisms of arrhythmias: from calcium dysregulation to syndromic signatures

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Istaroxime and its metabolite analogue reduce reperfusion arrhythmias in isolated-perfused diabetic rat hearts and anesthetized diabetic rats
thumbnail
Congress Presentation
Digging into the pathophysiological complexity of CPVT5
thumbnail
Congress Presentation
Effect of the beta-2-selective agonist Salbutamol and the beta-1- selective antagonist Bisoprolol in a murine model of HFpEF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources